BioNexus Gene Lab Corp's total assets for Q4 2025 were $9.25M, an increase of 21.41% from the previous quarter. BGLC total liabilities were $637.86K for the fiscal quarter, a -20.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.